Outlook Therapeutics (OTLK) Institutional Ownership $1.46 -0.01 (-0.68%) (As of 09:34 AM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Outlook Therapeutics (NASDAQ:OTLK)CurrentInstitutional OwnershipPercentage11.20%Number ofInstitutional Buyers(last 12 months)12TotalInstitutional Inflows(last 12 months)$8.60MNumber ofInstitutional Sellers(last 12 months)8TotalInstitutional Outflows(last 12 months)$81.14M Get OTLK Insider Trade Alerts Want to know when executives and insiders are buying or selling Outlook Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data OTLK Institutional Buying and Selling by Quarter Ad Brownstone ResearchDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.I urge you to watch this video now. Outlook Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/19/2024 Barclays PLC20,943$111K0.0%+677.4%0.089% 11/16/2024 Geode Capital Management LLC341,959$1.83M0.0%+49.2%1.445% 11/15/2024 Barclays PLC20,943$111K0.0%+677.4%0.089% 11/15/2024 XTX Topco Ltd37,328$199K0.0%N/A0.158% 11/15/2024 Sphera Funds Management LTD.413,545$2.21M0.4%-27.6%1.748% 11/15/2024 State Street Corp232,542$1.24M0.0%+10.0%0.983% Get the Latest News and Ratings for OTLK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Outlook Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/14/2024 Caligan Partners LP318,699$1.70M0.5%-36.3%1.347% 11/13/2024 Great Point Partners LLC1,293,028$6.91M2.0%-24.0%5.465% 11/12/2024 Charles Schwab Investment Management Inc.51,459$275K0.0%+55.1%0.217% 10/22/2024 Christensen King & Associates Investment Services Inc.10,276$55K0.0%N/A0.044% 8/15/2024Susquehanna Fundamental Investments LLC41,020$303K0.0%N/A0.175% 8/15/2024 AQR Capital Management LLC10,164$75K0.0%N/A0.043% 8/14/2024 Squarepoint Ops LLC31,388$232K0.0%N/A0.134% 8/14/2024 Great Point Partners LLC1,701,510$12.56M2.4%+15.0%7.270% 7/16/2024 LVW Advisors LLC47,730$352K0.1%N/A0.204% 7/12/2024 Rosalind Advisors Inc.450,000$3.32M2.4%+44.3%1.922% 5/20/2024 Virtu Financial LLC18,213$217K0.0%-73.3%0.140% 5/14/2024 American International Group Inc.3,873$46K0.0%-95.0%0.030% 5/10/2024 Vanguard Group Inc.341,300$4.08M0.0%-94.8%2.623% 5/1/2024 BNP Paribas Financial Markets4,505$54K0.0%-94.8%0.035% 4/25/2024 Rosalind Advisors Inc.311,775$3.72M3.5%N/A2.396% 2/12/2024 Scotia Capital Inc.284,080$112K0.0%-16.1%0.109% 11/15/2023 Scotia Capital Inc.338,439$75K0.0%+420.9%0.130% 11/3/2023 Gables Capital Management Inc.154,500$34K0.0%+132.3%0.059% 10/24/2023 Bank of New York Mellon Corp434,567$96K0.0%-8.3%0.167% 9/21/2023 Barclays PLC30,963$54K0.0%-60.9%0.012% 8/7/2023 Lincoln National Corp320,300$557K0.0%+64.8%0.125% 8/4/2023 Main Street Financial Solutions LLC25,000$44K0.0%N/A0.010% 8/3/2023 Scotia Capital Inc.64,976$113K0.0%N/A0.025% 7/18/2023Stratos Wealth Advisors LLC17,000$30K0.0%N/A0.007% 4/28/2023 SG Americas Securities LLC61,941$68K0.0%N/A0.024% 2/13/2023 GSA Capital Partners LLP277,785$300K0.0%+65.5%0.108% 2/10/2023 Vista Finance LLC277,615$300K0.4%-30.2%0.108% 2/8/2023 Lincoln National Corp194,300$210K0.0%+26.7%0.076% 2/7/2023 Metis Global Partners LLC48,289$52K0.0%+174.3%0.019% 1/17/2023 PPS&V Asset Management Consultants Inc.50,153$54K0.1%N/A0.022% 11/14/2022 Vista Finance LLC397,555$485K0.6%-61.0%0.176% 8/5/2022 Vista Finance LLC1,020,370$1.04M1.4%+3.7%0.452% 8/2/2022 Lincoln National Corp153,300$156K0.0%+48.4%0.068% 8/1/2022 Graypoint LLC37,500$38K0.0%-25.0%0.017% Why I'm telling friends to avoid gold stocks (Ad)Back in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."And if you’d like to get your hands on this, here you go, the complete breakdown.7/26/2022 First Merchants Corp149,170$151K0.0%+45.1%0.066% 7/22/2022 LVW Advisors LLC1,733,633$1.77M0.4%-0.6%0.767% 7/18/2022 Gables Capital Management Inc.61,500$63K0.0%+32.3%0.027% 7/12/2022 Flower City Capital51,778$53K0.1%+158.9%0.023% 5/11/2022 GSA Capital Partners LLP256,200$456K0.1%+22.0%0.114% 5/2/2022 Gables Capital Management Inc.46,500$83K0.1%+1,228.6%0.021% 4/26/2022 Vista Finance LLC983,645$1.75M2.6%N/A0.439% 4/26/2022 First Merchants Corp102,770$182K0.0%+201.9%0.046% 4/19/2022 Graypoint LLC50,000$89K0.0%N/A0.022% 4/14/2022 Flower City Capital20,000$36K0.0%N/A0.009% 2/14/2022 GSA Capital Partners LLP210,042$286K0.0%N/A0.094% 2/10/2022 Alamar Capital Management LLC20,000$27K0.0%N/A0.009% 2/9/2022 Principal Financial Group Inc.36,686$50K0.0%+92.8%0.016% 2/8/2022 ProShare Advisors LLC19,461$26K0.0%+70.5%0.009% 2/8/2022 Northern Trust Corp817,545$1.11M0.0%-2.1%0.365% 2/7/2022 SG Americas Securities LLC25,235$34K0.0%-43.7%0.011% 2/4/2022 Envestnet Asset Management Inc.36,461$50K0.0%N/A0.016% 2/4/2022IndexIQ Advisors LLC187,692$255K0.0%-6.1%0.084% 2/2/2022 KWB Wealth27,284$37K0.0%N/A0.012% 2/2/2022 Oppenheimer & Co. Inc.22,100$30K0.0%+71.3%0.010% 1/27/2022 First Merchants Corp34,044$46K0.0%N/A0.015% 1/26/2022 Lincoln National Corp103,300$140K0.0%-59.2%0.046% 11/16/2021 Stelac Advisory Services LLC390,000$846K0.2%+39.3%0.222% 11/16/2021 Two Sigma Advisers LP309,900$672K0.0%-55.5%0.177% 11/16/2021 Two Sigma Investments LP271,534$589K0.0%-69.5%0.155% 11/15/2021 AXA S.A.145,013$315K0.0%-53.6%0.083% 11/12/2021 Renaissance Technologies LLC254,781$553K0.0%N/A0.145% 11/12/2021 Geode Capital Management LLC1,552,438$3.37M0.0%+2.4%0.885% 11/10/2021 Goldman Sachs Group Inc.151,110$328K0.0%+1,327.6%0.086% 11/10/2021IndexIQ Advisors LLC199,822$434K0.0%+11.1%0.114% 11/10/2021 Citigroup Inc.11,445$25K0.0%+174.5%0.007% 11/9/2021 Barclays PLC36,396$79K0.0%+113.8%0.021% 11/9/2021BlackRock Inc.5,838,612$12.67M0.0%+1.5%3.330% 11/9/2021 Principal Financial Group Inc.19,025$41K0.0%+35.9%0.011% 11/5/2021 Advisor Group Holdings Inc.30,246$66K0.0%-52.6%0.017% 11/2/2021 New York State Common Retirement Fund35,884$78K0.0%-52.2%0.020% 11/1/2021 SG Americas Securities LLC44,828$97K0.0%N/A0.026% 10/29/2021Commonwealth Equity Services LLC21,522$46K0.0%N/A0.012% 10/28/2021Endurance Wealth Management Inc.15,000$33K0.0%N/A0.009% 10/22/2021 Strs Ohio27,000$58K0.0%+33.0%0.015% 10/18/2021 Coastal Investment Advisors Inc.16,000$35K0.0%+45.5%0.009% 8/17/2021 Walleye Capital LLC29,000$72K0.0%N/A0.017% 8/16/2021 Squarepoint Ops LLC11,200$28K0.0%-37.4%0.006% 8/16/2021 AQR Capital Management LLC35,995$90K0.0%N/A0.021% 8/16/2021 Amalgamated Bank16,537$41K0.0%N/A0.010% 8/16/2021 California State Teachers Retirement System121,237$302K0.0%N/A0.070% 8/16/2021 Charles Schwab Investment Management Inc.220,066$548K0.0%+539.1%0.127% 8/16/2021 State Street Corp1,342,514$3.34M0.0%N/A0.773% 8/16/2021 Nuveen Asset Management LLC187,652$468K0.0%N/A0.108% 8/13/2021 Northern Trust Corp880,428$2.19M0.0%+407.5%0.507% Will the Nasdaq 100 crash? (Ad)In a world where some top money managers say you should “diversify” with a basket of stocks to help lower risk in your portfolio… And others say you should focus on only one ticker at a time because you can’t really keep detailed tabs on 10, 20 or more stocks at once… My #1 strategy to play the Nasdaq bull run has shown the power to provide the best of BOTH worlds at the same time. Because it harnesses ONE ticker that bottles up all the firepower of Apple, Nvidia, Tesla and more into one place… While I cannot promise future returns or against losses… This strategy targets major payouts OVERNIGHT!Click here to get the details.8/13/2021 TrinityPoint Wealth LLC10,000$25K0.0%N/A0.006% 8/13/2021 Lincoln National Corp253,300$631K0.0%N/A0.146% 8/13/2021 AXA S.A.312,303$778K0.0%-24.6%0.180% 8/13/2021 Geode Capital Management LLC1,516,087$3.78M0.0%+104.4%0.873% 8/13/2021 Vanguard Group Inc.4,634,410$11.54M0.0%+11.3%2.669% 8/13/2021 ProShare Advisors LLC22,719$57K0.0%N/A0.013% 8/12/2021 XTX Topco Ltd10,871$27K0.0%N/A0.006% 8/12/2021 JPMorgan Chase & Co.33,623$84K0.0%N/A0.019% 8/11/2021 Bank of New York Mellon Corp232,474$578K0.0%+144.2%0.134% 8/11/2021BlackRock Inc.5,753,938$14.33M0.0%+230.2%3.314% (Data available from 1/1/2016 forward) OTLK Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of OTLK shares? During the previous two years, 29 institutional investors and hedge funds held shares of Outlook Therapeutics. The most heavily invested institutionals were Great Point Partners LLC ($6.91M), Vanguard Group Inc. ($4.08M), Rosalind Advisors Inc. ($3.32M), Sphera Funds Management LTD. ($2.21M), Geode Capital Management LLC ($1.83M), Caligan Partners LP ($1.70M), and State Street Corp ($1.24M).Learn more on OTLK's institutional investors. What percentage of Outlook Therapeutics stock is owned by institutional investors? 11.20% of Outlook Therapeutics stock is owned by institutional investors. Learn more on OTLK's institutional investor holdings. Which institutional investors have been buying Outlook Therapeutics stock? Of the 21 institutional investors that purchased Outlook Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Rosalind Advisors Inc. ($450K), Scotia Capital Inc. ($338.44K), Great Point Partners LLC ($221.51K), Lincoln National Corp ($167K), Geode Capital Management LLC ($112.81K), GSA Capital Partners LLP ($109.96K), and Gables Capital Management Inc. ($88K). How much institutional buying is happening at Outlook Therapeutics? Institutional investors have bought a total of 1,926,392 shares in the last 24 months. This purchase volume represents approximately $24.66M in transactions. Which Outlook Therapeutics major shareholders have been selling company stock? Of the 11 institutional investors that sold Outlook Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Vanguard Group Inc. ($6.22M), Great Point Partners LLC ($408.48K), Caligan Partners LP ($181.30K), Sphera Funds Management LTD. ($157.88K), Vista Finance LLC ($119.94K), BNP Paribas Financial Markets ($81.88K), and American International Group Inc. ($74.30K). How much institutional selling is happening at Outlook Therapeutics? Institutional investors have sold a total of 7,434,664 shares in the last 24 months. This volume of shares sold represents approximately $85.58M in transactions. Related Companies Tenaya Therapeutics Institutional Ownership Protalix BioTherapeutics Institutional Ownership Atossa Therapeutics Institutional Ownership Actuate Therapeutics Institutional Ownership Black Diamond Therapeutics Institutional Ownership Cabaletta Bio Institutional Ownership Cassava Sciences Institutional Ownership Inventiva Institutional Ownership X4 Pharmaceuticals Institutional Ownership Alto Neuroscience Institutional Ownership This page (NASDAQ:OTLK) was last updated on 12/26/2024 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredElon Musk could help pay for your retirementElon Musk is the richest man in the world... And he's pouring trillions into a unique investment.Brownstone Research | SponsoredTSLA *BANG* incoming (bullet in the chamber rn)I just pinpointed 5 dirt-cheap stocks that could soar the second the shot goes off. Thanks to Donald Trump’...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Outlook Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Outlook Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
